Ilya Rachman - Dec 15, 2021 Form 3 Insider Report for Immix Biopharma, Inc. (IMMX)

Role
CEO and Chairman, Director
Signature
/s/ Ilya Rachman
Stock symbol
IMMX
Transactions as of
Dec 15, 2021
Transactions value $
$0
Form type
3
Date filed
12/15/2021, 08:05 PM
Next filing
Dec 20, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding IMMX Common stock 900K Dec 15, 2021 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding IMMX Options (right to purchase) Dec 15, 2021 Common stock 270K $1.86 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On June 18, 2021, the Registrant issued the Reporting Person options to purchase up to 270,000 shares of the Registrant's common stock (the "Options"). The Options vest in 48 monthly installments with the first installment vesting on June 18, 2021.

Remarks:

Exhibit List: Exhibit 24.1 - Power of Attorney